Altered bed nucleus of the stria terminalis and amygdala responses to threat in combat veterans with posttraumatic stress disorder.


Journal

Journal of traumatic stress
ISSN: 1573-6598
Titre abrégé: J Trauma Stress
Pays: United States
ID NLM: 8809259

Informations de publication

Date de publication:
04 2023
Historique:
revised: 15 12 2022
received: 05 07 2022
accepted: 16 12 2022
pmc-release: 01 04 2024
medline: 13 4 2023
pubmed: 21 3 2023
entrez: 20 3 2023
Statut: ppublish

Résumé

Posttraumatic stress disorder (PTSD) significantly impacts many veterans. Although PTSD has been linked to alterations in the fear brain network, the disorder likely involves alterations in both the fear and anxiety networks. Fear involves responses to imminent, predictable threat and is driven by the amygdala, whereas anxiety involves responses to potential, unpredictable threat and engages the bed nucleus of the stria terminalis (BNST). The BNST has been implicated in PTSD, but the role of the BNST in combat veterans with PTSD has yet to be examined. Identifying alterations in BNST responses to unpredictable threat could provide important new targets for treatment. The current study examined whether veterans with PTSD have altered BNST or amygdala responses (function and connectivity) to unpredictable and predictable threat. The fMRI task involved viewing predictable threat cues followed by threat images, predictable neutral cues followed by neutral images, and unpredictable threat cues followed by either a threat or neutral image. Participants included 32 combat-exposed veterans with PTSD and 13 combat-exposed controls without PTSD. Across all conditions, veterans with PTSD had heightened BNST activation and displayed stronger BNST and amygdala connectivity with multiple fear and anxiety regions (hypothalamus, hippocampus, insula, ventromedial prefrontal cortex) relative to controls. In contrast, combat controls showed a pattern of stronger connectivity during neutral conditions (e.g., BNST-vmPFC), which may suggest a neural signature of resilience to developing PTSD, η

Identifiants

pubmed: 36938747
doi: 10.1002/jts.22918
pmc: PMC10548436
mid: NIHMS1922165
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

359-372

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Organisme : VA
ID : CX001226
Pays : United States
Organisme : NIH HHS
ID : UL-1-TR000445
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH018921
Pays : United States
Organisme : NIH HHS
ID : T32MH01892
Pays : United States
Organisme : CSRD VA
ID : I01 CX001226
Pays : United States

Informations de copyright

© 2023 International Society for Traumatic Stress Studies.

Références

Trends Cogn Sci. 2021 Dec;25(12):1021-1032
pubmed: 34625348
Neuroscience. 2004;128(1):7-14
pubmed: 15450349
Cochrane Database Syst Rev. 2013 Dec 13;(12):CD003388
pubmed: 24338345
Brain Behav. 2021 Jan;11(1):e01952
pubmed: 33205889
Hum Brain Mapp. 2017 Apr;38(4):2190-2205
pubmed: 28070973
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
BMC Psychiatry. 2018 May 15;18(1):129
pubmed: 29764396
Psychol Assess. 2018 Mar;30(3):383-395
pubmed: 28493729
Psychol Sci. 2007 Feb;18(2):127-9
pubmed: 17425531
J Neurosci. 2014 Aug 20;34(34):11261-73
pubmed: 25143607
Hum Brain Mapp. 2018 Mar;39(3):1367-1379
pubmed: 29266586
Arch Gen Psychiatry. 1995 Dec;52(12):1048-60
pubmed: 7492257
Biol Psychiatry. 2005 Mar 1;57(5):464-73
pubmed: 15737660
Am Heart J. 2013 Nov;166(5):806-14
pubmed: 24176435
Neurosci Lett. 2019 Feb 6;693:58-67
pubmed: 29195911
Am J Psychiatry. 2005 Feb;162(2):214-27
pubmed: 15677582
Psychiatry Res. 2015 Oct 30;234(1):96-105
pubmed: 26347412
Biol Psychiatry. 2000 May 1;47(9):769-76
pubmed: 10812035
Biol Psychiatry. 2010 Dec 1;68(11):1023-30
pubmed: 20855060
Mol Psychiatry. 2016 Apr;21(4):450-63
pubmed: 26878891
Neuropsychopharmacology. 2016 Jan;41(1):126-41
pubmed: 26105138
J Psychiatr Res. 2013 Oct;47(10):1469-78
pubmed: 23827769
Neuropsychopharmacology. 2014 Jan;39(2):351-9
pubmed: 23929546
Cell Rep. 2020 Aug 25;32(8):108066
pubmed: 32846124
Behav Brain Res. 2021 Aug 27;412:113428
pubmed: 34182009
Neuroimage. 2014 May 1;91:311-23
pubmed: 24444996
Neuroimage Clin. 2019;22:101735
pubmed: 30878610
J Psychiatry Neurosci. 2019 Apr 09;44(5):313-323
pubmed: 30964612
Psychol Med. 2017 Nov;47(15):2675-2688
pubmed: 28485259
Arch Gen Psychiatry. 1997 Mar;54(3):233-41
pubmed: 9075464
Neuroimage Clin. 2020;28:102442
pubmed: 33070099
Front Behav Neurosci. 2019 Apr 05;13:68
pubmed: 31024271
Neuroimage. 2020 Apr 15;210:116555
pubmed: 31954845
Transl Psychiatry. 2020 Feb 10;10(1):61
pubmed: 32066690
Nat Rev Neurosci. 2012 Nov;13(11):769-87
pubmed: 23047775
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
JAMA Psychiatry. 2013 Sep;70(9):949-55
pubmed: 23863892
Hum Brain Mapp. 2018 Mar;39(3):1291-1312
pubmed: 29235190
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9203-8
pubmed: 22623532
J Psychiatr Res. 2013 Nov;47(11):1766-75
pubmed: 23992768
J Behav Ther Exp Psychiatry. 2013 Mar;44(1):69-76
pubmed: 22922079
Neuropsychopharmacology. 1999 Jul;21(1):40-50
pubmed: 10379518
Biol Psychiatry. 2010 Sep 1;68(5):416-24
pubmed: 20497902
Biol Psychiatry. 2007 Sep 1;62(5):446-54
pubmed: 17217927
J Neurosci. 2020 Oct 7;40(41):7949-7964
pubmed: 32958570
Curr Opin Neurobiol. 2004 Apr;14(2):198-202
pubmed: 15082325
Nat Neurosci. 2002 Nov;5(11):1242-7
pubmed: 12379862
Depress Anxiety. 2019 Aug;36(8):666-675
pubmed: 30953446
Medicine (Baltimore). 2016 Jul;95(27):e4083
pubmed: 27399097
PLoS One. 2008 Jul 02;3(7):e2570
pubmed: 18596957
Neuroimage. 2004 Oct;23(2):752-63
pubmed: 15488425
J Anxiety Disord. 2015 Apr;31:98-107
pubmed: 25768399
Learn Mem. 2017 Aug 16;24(9):480-491
pubmed: 28814474
Neuroimage. 2014 Jan 1;84:1042-52
pubmed: 24055504
Front Psychiatry. 2011 Nov 14;2:62
pubmed: 22102841
Soc Cogn Affect Neurosci. 2011 Jan;6(1):74-81
pubmed: 20207692

Auteurs

Brandee Feola (B)

Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Elizabeth A Flook (EA)

Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Hannah Gardner (H)

Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

K Luan Phan (KL)

Department of Psychiatry, The Ohio State University, Columbus, Ohio, USA.

Harry Gwirtsman (H)

Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Tennessee Valley HealthCare System, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA.

Bunmi Olatunji (B)

Department of Psychology, Vanderbilt University, Nashville, Tennessee, USA.

Jennifer Urbano Blackford (JU)

Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Tennessee Valley HealthCare System, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA.
Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH